Polyclonal Antibodies
Anti-TWEAKR/Fn14/CD266 Polyclonal Antibody for WB - Q9NP84
Item Number : CM0013660
Price varies based on specs and customizations
- Application
- WB, ELISA
- Cross Reactivity
- Human
- Protein Weight
- 14kDa
Shipping:
Contact us to get shipping details Enjoy On-time Dispatch Guarantee.
Why Choose Us
Easy ordering process, quality products, and dedicated support for your business success.
Core Product Specifications and Parameters
| Parameter | Value |
|---|---|
| Product Name | TWEAKR/Fn14/CD266 Rabbit pAb |
| Remarks/Alias | FN14; CD266; TWEAKR; TWEAKR/Fn14/CD266 |
| Species | Human |
| GeneID (human) | 51330 |
| GeneID | 51330 |
| Immunogen | Recombinant fusion protein containing a sequence corresponding to amino acids 28-129 of human TWEAKR/Fn14/CD266 (NP_057723.1) |
| Source | Rabbit |
| Category | Polyclonal Antibodies |
| Application | WB, ELISA |
| Cross Reactivity | Human |
| SWISS | Q9NP84 |
| Protein Weight | 14kDa |
| Shipping | Ice bag |
Biological Background: TWEAKR/Fn14/CD266 Function and Localization
- TWEAKR (TNFRSF12A, also known as Fn14/CD266) is the receptor for the cytokine TWEAK (TNFSF12), a member of the tumor necrosis factor superfamily.
- Upon ligand binding, TWEAKR weakly induces apoptosis in some cell types and promotes angiogenesis and endothelial cell proliferation, implicating it in tissue repair and inflammation.
- The protein may also modulate cellular adhesion to matrix proteins, suggesting a role in cell-matrix interactions and migration.
- TWEAKR is a single-pass type I membrane protein, located at the plasma membrane, and contains a cysteine-rich domain characteristic of TNF receptor family members.
- It is expressed highly in heart, placenta, and kidney, with intermediate levels in lung, skeletal muscle, and pancreas, indicating tissue-specific functions.
- Alternative splicing generates multiple transcript variants, potentially contributing to functional diversity.
- Key structural features include a signal peptide, a transmembrane helix, and conserved disulfide bonds, ensuring proper folding and receptor signaling.
Experimental Guidance and Technical Tips
- The immunogen comprises the extracellular domain (amino acids 28-129), suggesting the antibody recognizes the ligand-binding region; confirm specificity via knockdown or knockout controls in WB experiments.
- For Western blot, use reducing SDS-PAGE; the predicted molecular weight is approximately 14 kDa, but consider that glycosylation may cause a slightly higher apparent mass.
- In ELISA, the antibody can be used as a capture or detection reagent; optimize coating conditions and antibody concentrations with a recombinant TWEAKR protein standard.
- When working with human samples, note the high expression in heart, placenta, and kidney; validate performance in lysates from these tissues or relevant cell lines.
CamelBio: Your One-Stop Sourcing Bridge
CamelBio offers comprehensive IVD raw-material solutions, from validated antibody pairs to bulk ancillary reagents, supporting your TNFRSF12A/TWEAKR research needs. We supply this anti-TWEAKR polyclonal antibody for applications like WB and ELISA, and can assist in sourcing rare-target reagents or developing custom antibody sets for your diagnostic assays. Our B2B platform streamlines procurement, helping you move from concept to clinic with reliable, high-quality materials.
Product Datasheet
Anti-TWEAKR/Fn14/CD266 Polyclonal Antibody for WB - Q9NP84
REQUEST A QUOTE
Our professional team will reply to you within one business day. Please feel free to contact us!